Related Experiment Video

Updated: Jul 28, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Statins and blood pressure regulation

C Borghi1, M Veronesi, M G Prandin

  • 1Divisione di Medicina Interna, Policlinico S. Orsola, Via Massarenti 9, 40138 Bologna, Italy. claudio@med.unibo.it

Current Hypertension Reports
|July 27, 2001
PubMed

Insights

Statins, commonly used for high cholesterol, significantly lower blood pressure in hypertensive patients, including those with diabetes. This blood pressure reduction is independent of cholesterol levels and aids cardiovascular disease prevention.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Hypertension and hypercholesterolemia are key risk factors for cardiovascular diseases (CVD).
  • Combined increases in both risk factors are common in coronary artery disease patients.
  • Statins, primarily for hypercholesterolemia, may influence blood pressure control.

Purpose of the Study:

  • To investigate the effect of statins on blood pressure control in hypertensive patients.
  • To explore potential mechanisms behind statins' hypotensive effects.
  • To assess the role of statins in integrated CVD prevention strategies.

Main Methods:

  • Review of studies on statin use in hypertensive populations.
  • Analysis of blood pressure changes in patients treated with statins.
  • Exploration of mechanisms including endothelial function and angiotensin II receptors.

Main Results:

  • Statins significantly reduced blood pressure in patients with untreated hypertension.
  • Blood pressure reduction was observed in patients on antihypertensive drugs, especially ACE inhibitors and calcium channel blockers.
  • Statins also demonstrated a hypotensive effect in diabetic patients.
  • The blood pressure-lowering effect appears independent of lipid-lowering effects.

Conclusions:

  • Statins possess a hypotensive effect in various hypertensive patient groups.
  • Mechanisms may involve endothelial function and angiotensin II pathways, distinct from lipid modification.
  • Improving blood pressure control with statins offers a valuable component for comprehensive CVD prevention.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...